Heparin-binding secretory transforming gene (hst) facilitates rat lactotrope cell tumorigenesis and induces prolactin gene transcription

Journal of Clinical Investigation

Volumn 97, Issue 1, 1996, Pages 187-195

  Shimon, Ilan ^a   Hüttner, Anita ^a   Said, Jonathan ^a   Spirina, Olga M ^a   Melmed, Shlomo ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

fibroblast growth factor 4; growth factor; pituitary adenoma; prolactinoma

Indexed keywords

CYCLINE; FIBROBLAST GROWTH FACTOR 4; GROWTH HORMONE; LUCIFERASE; PROLACTIN; RECOMBINANT FIBROBLAST GROWTH FACTOR 4; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; DNA TRANSFECTION; FEMALE; GENE INDUCTION; GROWTH HORMONE RELEASE; HYPOPHYSIS TUMOR; NONHUMAN; PRIORITY JOURNAL; PROLACTIN RELEASE; PROLACTINOMA; PROTO ONCOGENE; RAT;

EID: 0030061454     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118388     Document Type: Article

References (55)

1. Melmed, S. 1993 Pathogenesis of pituitary tumors. In Molecular Genetics of Nervous System Tumors. A. J. Levine and H. H. Schmidek, editors. Wiley-Liss. Inc., New York, 255-263.
2. Herman, V., J. Fagin, R. Gonsky, K. Kovacs, and S Melmed. 1990. Clonal origin of secretory and non-secretory pituitary adenomas J. Clin Endocrinol. & Metab. 71:1427-1433.
3. Alexander, J. M., B. M. Biller, H. Bikkai, N. T. Zervas A. Arnold, and A. Klibanski 1990. Clinically nonfunctioning pituitary tumors are monoclonal in origin. J Clin. Invest 86:336-340.
4. Vallar, L , A. Spada, and O. Giannattasio 1987. Altered Gs and adenylate cyclase activity in human GH-secretmg pituitary adenomas. Nature (Lond ). 330.566-568.
5. Bystrom. C., C Larsson, C. Blomberg, K. Sandelin, U. Falkmer, B. Skogscid, K. Oberg. S. Werner, and M. Nordenskjold. 1990. Localization of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumors. Proc. Natl. Acad. Sci. USA. 87:1968-1972.
6. Herman, V., N. Z. Diazin, R. Gonsky, and S. Melmed. 1993. Molecular screening of pituitary adenomas for gene mutations and rearrangements. J Clin. Endocrinol. & Metab. 77:50-55.
7. Boggild, M. D., S. Jenkinson. M. Pistorello, M. Boscaro, M. Scanarim, P. McTernan, C. W. Perrett, R. V. Thakker, and R. N. Clayton. 1994. Molecular genetic studies of sporadic pituitary tumors. J. Clin. Endocrinol & Metab. 78 387-392.
8. Sakamoto, H., M. Mori, M. Taira, T. Yoshida, S Matsukawa, K. Shimizu, M. Sekiguchi, M. Terada, and T. Sugimura. 1986. Transforming gene from human stomach cancers and a noncancerous portion of stomach mucosa. Proc. Natl. Acad. Sci. USA. 83:3997-4001.
9. Benhairoch, D., and D. Birnbaum. 1990 Biology of the fibroblast growth factor gene family, Isr. J. Med. Sci. 26:212-219.
10. Mason, I. J. 1994. The ins and outs of fibroblast growth factors Cell 78: 547-552.
11. Rifkin, D. B., and D Moscatelli. 1989. Recent developments in the cell biology of basic fibroblast growth factor. J. Cell Biol. 109:1-6
12. Taira, M. T. Yoshida, K. Miyagawa, H. Skamoto, M. Terada, and T. Sugimura 1987. cDNA sequence of human transforming gene hst and identification of the coding sequence required for transforming activity. Proc. Natl Acad. Sci. USA. 84:2980-2984.
13. Yoshida, T., K Miyagawa, H Odagiri, H. Sakamoto. P. F. Little. M Terada. and T. Sugimura. 1987. Genomic sequence of hst, a transforming gene encoding a protein homologous to fibroblast growth factors and the int-2-encoded protein. Proc Natl Acad Sci USA 84.7305-7309.
14. Yoshida, M C., M. Wada, H. Satoh, T. Yoshida, H. Sakamoto, K. Miyagawa, J. Yokota, T. Koda, M. Kakinuma, T. Sugimura, and M Terada. 1988 Human HSTI (HSTF1) gene maps to chromosome band 11q13 and coamplifies with the INT2 gene in human cancer Proc. Natl. Acad. Sci. USA 85:4861-4864.
15. Delli Bovi, P , A. M. Curatola, F. G. Kern, A. Greco, M. Ittmann. and C. Basilico. 1987. An oncogene isolated by transfection of Kaposi's sarcoma DNA encodes a growth factor that is a member of the FGF family. Cell 50:729-737.
16. Delli Bovi, P., and C Basilico. 1987 Isolation of a rearranged human transforming gene following transfection of Kaposi sarcoma DNA. Proc Natl Acad. Sci. USA. 84 5660-5664.
17. Adelaide, J., M. G. Mattei. I. Maries, F. Raybaud, J. Planche, O D. Lapeynere, and D. Birnbaum. 1988. Chromosomal localization of the list oncogene and its co-amplification with the int-2 oncogene in human melanoma. Oncogene. 2:413-416.
18. Velcich, A., P. Delli-Bovi, A. Mansukham, E. B. Ziff, and C. Basilico 1989. Expression of the K-fgf protooncogene is repressed during differentiation of F9 cells. Oncogene Res. 5:31-37.
19. Nakagama, H., S. Ohnishi, M. Imawan, H. Hirai, F. Takaku, H. Sakamoto, M. Terada, M. Nagao, and T. Sugimura. 1987. Identification of trans forming genes as hst in DNA samples from two human hepatocellular carcinomas. Jpn. J. Cancer Res 78:651-654.
20. Tsuda, T., H. Nakatani, T Matsumura, K. Yoshida, E Tahara, T. Nishihira, H. Sakamoto, T. Yoshida, M. Terada, and T. Sugimura. 1988. Amplification of the hst-1 gene in human esophageal carcinomas. Jpn. J. Cancer Res. 79. 584-588.
21. Strohmeyer, T., S. Peter, M. Hartmann, S. Munemistu, R. Ackermann, A. Ullrich, and D. J Slamon. 1991. Expression of the hst-1 and c-kit protooncogenes in human testicular germ cell tumors. Cancer Res. 51:1811-1816
22. Talarico, D., and C. Basilico, 1991 The K-fgf/hst oncogene induces transformation through an autocrine mechanism that requires extracellular stimulation of the mitogenic pathway. Mol Cell Biol. 11:1138-1145.
23. Feldman, B., W Poueymirou, V. E. Papaioannou, T. M. DeChiara, and M. Goldfarb. 1995 Requirement of FGF-4 for postimplantation mouse development. Science (Wash. DC). 267:246-249
24. Niswander, L., S. Jeffrey, G. R. Martin, and C. Tickle. 1994. A positivefeedback loop coordinates growth and patterning in the vertebrate limb. Nature (Lond ). 371:609-612.
25. Delli Bovi, P., A. M. Curatola, K. M. Nweman, Y. Sato, D. Moscatelli, R M. Hewick, D B. Rifkin, and C. Basilico. 1988. Processing, secretion, and biological properties of a novel growth factor of the fibroblast growth factor family with oncogenic potential. Mol Cell. Biol. 8:2933-2941.
26. Gospodarowicz, D 1975. Purification of a fibroblast growth factor from bovine pituitary. J. Biol. Chem 250:2515-2520.
27. Bohlen, P., A Baird, F. Esch, N. Ling, and D. Gospodarowicz. 1984. Isolation and partial molecular characterization of pituitary fibroblast growth factor Proc Natl Acad Sci. USA. 81:5364-5368.
28. Li. Y., M Koga. S Kasayama. K Kasayama, K Arita, T. Hayakawa, and B. Sato 1992. Identification and characterization of high molecular weight forms of basic fibroblast growth factor in human pituitary adenomas. J. Clin. Endocrinol. & Metab. 75.1436-1441.
29. Baird, A , P Mormede, S. Y. Ying, W. B. Wehrenberg. N. Ueno. N Ling, and R. Guillemin. 1985. A nonmilogenic pituitary function of fibroblast growth factor: regulation of thyrotropm and prolactin secretion Proc Natl Acad Sci. USA 82:5545-5549.
30. Atkin, S. L., A. M. Landolt, R. V. Jeffreys, M. Diver, J. Radcliffe, and M C. White. 1993. Basic fibroblast growth factor stimulates prolactin secretion from human anterior pituitary adenomas without affecting adenoma cell proliferation J. Clin. Endocrinol. & Metab 77:831-837.
31. Zimering, M. B., M. L. Brandi, D. A. deGrange, S. J. Marx, E. Streeten, N Katsumata, P. R. Murphy, Y. Sato, H. G Friesen, and G D. Aurbach. 1990 Circulating fibroblast growth factor-like substance in familial multiple endocrine neoplasia type 1. J Clin. Endocrinol & Metab 70.149-154.
32. Zimenng, M. B., N. Katsumata, Y Sato, M. L. Brandi, G. D Aurbach, S. J. Marx, and H. G. Friesen. 1993. Increased basic fibroblast growth factor in plasma from multiple endocrine neoplasia type 1: relation to pituitary tumor. J. Clin. Endocrinol. & Metab. 76:1182-1187.
33. Gonsky, R., V. Herman, S. Melmed, and J. Fagin 1991. Transforming DNA sequences present in human prolactin-secreting pituitary tumors. Mol. Endocrinol. 5.1687-1695.
34. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-termination inhibitors. Proc Natl. Acad. Sci USA 74:5463-5467.
35. Feigner, P. L., T. R. Gadek, M. Holm. R. Roman, H. W Chan, M. Wenz. J. P. Northrop, G M Ringold. and M. Danielsen. 1987. Lipofectin, a highly efficient, hpid-mediated DNA-transfection procedure. Proc Natl. Acad Sci USA. 84:7413-7417.
36. Chomczynski, P., and N. Sacchi. 1987. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
37. Brooks, S., R. Smith, J. Thurlow, C. Dickson, and G. Peters. 1989. The mouse homologue of hstlk-FGF sequence, genome organization and location relative to int-2. Nucleic Acids Res 17:4037-4045.
38. Akita, S., J Webster, S. G. Ren, H. Takino, J. Said, O. Zand, and S. Melmed. 1995. Human and murine pituitary expression of leukemia inhibitory factor. Novel intrapituitary regulation of adrenocorticotropin hormone synthesis and secretion. J. Clin Invest. 95:1288-1298.
39. Prager, D., H. Yamasaki, M. M. Weber, S Gebremedhin, and S Melmed. 1992. Human insulin-like growth factor I receptor function in pituitary cells is suppressed by a dominant negative mutant J. Clin Invest. 90.2117-2122.
40. de Wet, J. R., K. V. Wood, M. DeLuca, D. R. Helinski, and S. Subramani. 1987 Firefly lucifcrase genc. structure and expression in mammalian cells Mol Cell. Biol. 7.725-737.
41. Rugh, R. 1990 The Mouse - Its Reproduction and Development. Oxford University Press, Oxford. 38-39.
42. Hall, P. A., D. A. Levinson, A. L. Woods, C. C Yu. D. B. Kellock, J. A. Watkins, D. M Barnes, C. E Gillett, R Camplejohn, R. Dover, et al. 1990 Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections, an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 162:285-294.
43. Sebo, T. J., P. C. Roche, T. E. Witzig, and P J. Kurtin, 1993. Proliferative activity in non-Hodgkin's lymphomas. A comparison of the bromodeoxyuridine labeling index with PCNA immunostaining and quantitative image analysis. Am. J Clin. Pathol. 99.668-672.
44. Pinkus, O. S , J. L. Pinkus, N S Goldstein, I. P. Shintaku, and J. W. Said. 1995. A putative marker for B cell proliferations - staining profile of 426 paraffin-embedded tissues. Appt. Immunohistochem. 3:23-31.
45. Bacus, S , J. L. Flowers, M. F. Press. J. W. Bacus, and K. S McCarty, Jr. 1988. The evaluation of estrogen receptor in primary breast carcinoma by computer-assisted image analysis. Am. J. Clin. Pathol. 90:233-239.
46. Basilico, C., K. M. Newman, A. M. Curatola, D. Talarico, A. Mansukhani, A. Velcich, and P. Delli-Bovi. 1989. Expression and activation of the K-fgf oncogene. Ann. NY Acad Sci. 567:95-103.
47. Neufeld, G., and D. Gospodarowicz 1985. The identification and partial characterization of the fibroblast growth factor receptor of baby hamster kidney cells. J Biol. Chem. 260:13860-13868.
48. Moscatelli, D. 1987. High and low affinity binding sites for basic fibroblast growth factor on cultured cells: absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells. J Cell. Physiol 131:123-130.
49. Schonbrunn, A , M. Krasnoff, J M. Westendorf, and A. H. Tashjian, Jr. 1980. Epidermal growth factor and thyrotropin-releasing hormone act similarly on a clonal pituitary cell strain. J. Cell Biol. 85:786-797.
50. Supowit, S C , E Potter, R M. Evans, and M. G. Rosenfeld. 1984 Polypeptide hormone regulation of gene transcription: specific 58′ genomic sequences are required for epidermal growth factor and phorbol ester regulation of prolactin gene expression. Proc. Natl. Acad. Sci USA. 81:2975-2979.
51. Berwaer, M., P. Monget, B Peers, M. Mathy-Hartert, E Bellefroid, J. R. Davis. A Belayew, and J. A. Martial. 1991. Multihormonal regulation of the human prolactin gene expression from 5000 bp of its upstream sequence. Mol Cell. Endocrinol 80:53-64.
52. Ran, M., F. Wang, J. Xu, J. W. Crabb, J. Hou, and W. L. McKeehan. 1993. An essential heparin-binding domain in the fibroblast growth factor receptor kinasc. Science (Wash DC) 259:1918-1921
53. Miyagawa, K., H. Sakamoto, T. Yoshida, Y. Yamashita, Y. Mitsui, M. Furusawa. S. Maeda, F. Takaku, T. Sugimura, and M. Terada 1988. hst-1 transforming protein. expression in silkworm cells and characterization as a novel heparin-binding growth factor. Oncogene. 3:383-389.
54. Yoshida, T., K. Ishimaru, H. Sakamoto, J. Yokota, S. Hirohashi, K. Igarashi, K. Sudo, and M. Terada. 1994. Angiogenic activity of the recombinant hsf-1 protein. Cancer Lett 83:261-268
55. Schechter, J., P. Goldsmith, C. Wilson, and R. Weiner. 1988. Morphological evidence for the presence of arteries in human prolactinomas. J Clin Endocrinol & Metab 67:713-719.